T3 Euthyroidism in Follicular Thyroid Carcinoma

  1. UDAYA M. KABADI, M.D., F.R.C.P.(C); and
  2. JOAN ALBIN, M.D.
  1. Gouverneur Hospital,
    New York, New York
  2. Montefiore Hospital and Medical Center,
    Bronx, New York

    Excerpt

    Follicular thyroid carcinoma comprises about 25% of all thyroid cancers, and its malignancy generally exceeds that of papillary carcinoma. It spreads relatively early to distant sites such as bone, lungs, and liver by invasion of blood vessels, and regional lymph nodes are usually involved only late. Production of thyroid hormones is almost exclusively associated with the follicular histologic type. In many reported cases the production of thyroid hormones by metastases has been sufficient to cause hyperthyroidism. One of these cases was that of a patient with "T3 thyrotoxicosis" (1).

    We describe here a patient having metastatic follicular thyroid carcinoma with

    This 100-word excerpt has been provided in the absence of an abstract.

    Acknowledgments

    The authors thank Albert B. Eisenstein, M.D., Associate Chief of Staff Research, Veterans Administration Hospital, Brooklyn, New York; Jack Meyer, M.D., Department of Radiology, Veterans Administration Hospital, Bronx, New York; and Robert D. Leeper, M.D., Memorial Hospital, New York, New York, for their guidance and assistance in the management of our patient.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement